Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Eli Lilly and Company

Symbol: LLY     Sector: Healthcare     Industry: Drug Manufacturers

Dividend Yield
2.38%
Current Price
$108.29
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 10:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
5,092,200,000
5,092,200,000
1,138,700,000
3,953,500,000
2,691,700,000
1,261,800,000
4,241,600,000
12,597,500,000
38,006,800,000
35,441,800,000
2,480,300,000
2,036,400,000
2,354,900,000
2,137,100,000
15,965,100,000
-5,999,600,000
311,300,000
 
1,230,500,000

Financials 2018

Update: 2019-06-09 10:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
6,438,600,000
6,438,600,000
1,593,700,000
4,844,900,000
3,247,400,000
1,597,500,000
1,125,000,000
20,549,600,000
43,908,400,000
32,999,300,000
9,828,700,000
7,998,200,000
1,131,200,000
8,086,400,000
12,770,900,000
-850,000,000
1,448,700,000
 
1,453,800,000

Q 3

2018-09-30
6,061,900,000
6,061,900,000
1,562,300,000
4,499,600,000
2,897,000,000
1,602,600,000
1,149,500,000
20,685,900,000
44,625,100,000
30,474,200,000
13,076,600,000
8,960,000,000
1,002,200,000
9,036,100,000
12,676,900,000
2,156,400,000
2,121,800,000
 
1,343,300,000

Q 2

2018-06-30
6,355,200,000
6,355,200,000
1,702,700,000
4,652,500,000
2,931,900,000
1,720,600,000
-259,900,000
18,332,700,000
42,359,200,000
30,738,400,000
11,555,200,000
6,817,300,000
3,049,100,000
6,909,500,000
12,219,600,000
3,819,500,000
1,517,500,000
 
1,333,100,000

Q 1

2018-03-31
5,700,000,000
5,700,000,000
1,571,300,000
4,128,700,000
2,620,500,000
1,508,200,000
1,217,400,000
16,261,500,000
44,355,600,000
29,767,800,000
14,527,000,000
3,084,300,000
2,304,200,000
4,789,500,000
11,697,700,000
-3,600,300,000
436,500,000
 
1,176,900,000

Financials 2017

Update: 2019-06-09 10:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
6,160,700,000
6,160,700,000
1,564,300,000
4,596,400,000
3,314,200,000
1,282,200,000
-1,656,900,000
19,202,100,000
44,981,000,000
33,313,100,000
11,592,200,000
6,536,200,000
3,706,600,000
8,034,100,000
13,647,100,000
2,854,100,000
1,743,500,000
 
1,411,400,000